Cutting-Edge Long-Read Transcriptomics Research Published in Nature Methods

Cutting-Edge Long-Read Transcriptomics Research Published in Nature Methods

We are pleased to announce the publication of a comprehensive study in Nature Methods: Systematic Assessment of Long-read RNA-seq Methods for Transcript Identification and Quantification.

This research provides an in-depth evaluation of multiple long-read RNA sequencing technologies, comparing their effectiveness in transcript identification and quantification.
BioBam participation in this research highlights its expertise in long-read sequencing technologies and its commitment to advancing cutting-edge academic research. This research is a significant contribution to the field and sets a benchmark for current practices and guides future developments in transcriptome analysis.

The study systematically assessed long-read RNA sequencing techniques using data from diverse human, mouse, and manatee samples. The research highlights several critical findings. Longer, more accurate reads significantly improve the accuracy of transcript identification, particularly for detecting complex and rare transcripts that shorter reads might miss. Deeper sequencing enhances the quantification of transcripts, providing a more accurate measure of transcript abundance. Reference-based tools perform best for well-annotated genomes, demonstrating higher accuracy in identifying known transcripts. Additionally, incorporating extra data and biological replicates improves the detection of rare transcripts, enhancing the robustness of the analysis.

The study’s comprehensive evaluation provides valuable insights for researchers and practitioners in the field, offering guidelines for choosing the most effective methods for transcript identification and quantification. It also highlights the importance of using long-read sequencing technologies to achieve higher accuracy and deeper insights into transcriptomics.

For more details, read the full article here.

 

 

About the Author

Dr. Stefan Götz (CEO)

Stefan Götz is the founder and CEO of BioBam. Since founding the company in 2011, he has focused on helping researchers simplify genomics and omics data analysis through practical and accessible software solutions. Under his leadership, BioBam has supported scientists and institutions worldwide in advancing research in human health, agriculture, and environmental science. Stefan remains closely involved in product strategy, innovation, and customer-driven development. He holds a Ph.D. in bioinformatics and combines scientific expertise with entrepreneurial leadership to make advanced bioinformatics more accessible to the global research community.

 
IMG BLOG (23)

Blog Categories:

News

Releases, Media, Announcements, etc.

Use Cases, Reviews, Tutorials

Product Tutorial, Quickstarts, New Features, etc.

Video Tutorials

Helpful Features, Tips and Tricks

Tips And Tricks

Mini-tutorials for common use-cases and to address frequently asked questions FAQs

Most Popular:

Facebook
Twitter
LinkedIn
Email
Print